Drugs / MAG-Tn3
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02364492 | Feb 2015 → Oct 2019 | breast cancer | Institut Pasteur | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MAG-Tn3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02364492 ↗ |
| Modality | Vaccine | “The fully synthetic glycopeptide vaccine MAG-Tn3” PMID 32034426 ↗ Feb 2020 |